{
    "code": "02022251",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022251",
    "time": "2023-08-10 23:26:33",
    "許可證字號": "衛署藥輸字第022251號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/07\/28",
    "發證\/登錄日期": "87\/07\/28",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202225101",
    "中文品名": "岱比博〝爾速可愈〞注射液",
    "英文品名": "ACICLOVIR INTRAVENOUS INFUSION &quot;DBL&quot;",
    "適應症": "帶狀疱疹病毒及單純疱疹病毒引起之感染、預防骨髓移植及白血病所引起之免疫不全病人之單純疱疹感染、新生兒單純疱疹感染。",
    "劑型": "279注射液",
    "包裝": "10,20公撮小瓶裝 各100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ACYCLOVIR",
    "限制項目": "02輸　入",
    "申請商名稱": "輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "HOSPIRA AUSTRALIA PTY LTD.",
            "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓、3樓、1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818000100",
            "成分名稱": "ACYCLOVIR",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Aciclovir LLD Australia 20150609-3-110-03-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022251&Seq=006&Type=9"
        },
        {
            "title": "衛署藥輸022251-岱比博 爾速可愈 注射液-仿單-107-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022251&Seq=005&Type=9"
        },
        {
            "title": "Binder_Aciclovir_new address-110-03-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022251&Seq=007&Type=8"
        },
        {
            "title": "衛署藥輸022251-岱比博 爾速可愈 注射液-標籤 500mg-107-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022251&Seq=006&Type=8"
        },
        {
            "title": "衛署藥輸022251-岱比博 爾速可愈 注射液-標籤 250mg-107-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022251&Seq=005&Type=8"
        },
        {
            "title": "衛署藥輸022251-岱比博 爾速可愈 注射液-外盒 500mg-107-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022251&Seq=004&Type=8"
        },
        {
            "title": "衛署藥輸022251-岱比博 爾速可愈 注射液-外盒 250mg-107-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022251&Seq=003&Type=8"
        }
    ]
}